Hutch News

Hutch News

Stories tagged 'AMP study'

Highlights of Fred Hutch science in 2018

A look back at notable advances in immunotherapy, precision screening and more

Dec. 18, 2018 | By Fred Hutch News Service staff

From basic biology to survivors’ pocketbooks, our researchers explore every angle of cancer. Here are just a few of the strides our teams made in 2018.

View story >


Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic

Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service

A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.

View story >


New 'mosaic' HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic

Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service

The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.